Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Raymond F. Anton |
Documentos disponibles escritos por este autor (6)
Refinar búsquedaEfficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence / Raymond F. Anton en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 4 (Agosto)
Título : Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence : Relationship to alcohol withdrawal symptoms Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Hugh Myrick, Autor ; Alicia M. Baros, Autor Fecha de publicación: 2022 Artículo en la página: pp. 334-342 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Tratamiento, Flumazenil, Gabapentina, Abstinencia alcohólica Resumen: Improved treatment of alcohol dependence is a high priority, including defining subtypes that might respond differently. We evaluated a medication combination of intravenous flumazenil (FMZ) and oral gabapentin (GBP) in alcoholics who did and did not exhibit pretreatment alcohol withdrawal (AW) symptoms. Link: ./index.php?lvl=notice_display&id=29494
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 4 (Agosto) . - pp. 334-342[artículo] Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence : Relationship to alcohol withdrawal symptoms [texto impreso] / Raymond F. Anton, Autor ; Hugh Myrick, Autor ; Alicia M. Baros, Autor . - 2022 . - pp. 334-342.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 4 (Agosto) . - pp. 334-342
Palabras clave: Alcoholismo, Tratamiento, Flumazenil, Gabapentina, Abstinencia alcohólica Resumen: Improved treatment of alcohol dependence is a high priority, including defining subtypes that might respond differently. We evaluated a medication combination of intravenous flumazenil (FMZ) and oral gabapentin (GBP) in alcoholics who did and did not exhibit pretreatment alcohol withdrawal (AW) symptoms. Link: ./index.php?lvl=notice_display&id=29494
Título : A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Helen Pettinati, Autor ; Allen Zweben, Autor Fecha de publicación: 2023 Artículo en la página: pp. 421-428 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Relación Dosis-Respuesta, Naltrexona - efectos adversos Resumen: The opiate antagonist nalmefene has been shown in 2 single-site studies to reduce alcohol consumption and relapse drinking in alcohol-dependent individuals. This safety and preliminary multisite efficacy study evaluated 3 doses of nalmefene (5, 20, or 40 mg) in a double-blind comparison to placebo over a 12-week treatment period in 270 recently abstinent outpatient alcohol-dependent individuals. Link: ./index.php?lvl=notice_display&id=30956
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 4 (Agosto) . - pp. 421-428[artículo] A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence [texto impreso] / Raymond F. Anton, Autor ; Helen Pettinati, Autor ; Allen Zweben, Autor . - 2023 . - pp. 421-428.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 4 (Agosto) . - pp. 421-428
Palabras clave: Alcoholismo, Relación Dosis-Respuesta, Naltrexona - efectos adversos Resumen: The opiate antagonist nalmefene has been shown in 2 single-site studies to reduce alcohol consumption and relapse drinking in alcohol-dependent individuals. This safety and preliminary multisite efficacy study evaluated 3 doses of nalmefene (5, 20, or 40 mg) in a double-blind comparison to placebo over a 12-week treatment period in 270 recently abstinent outpatient alcohol-dependent individuals. Link: ./index.php?lvl=notice_display&id=30956
Título : Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Darlene H. Moak, Autor ; Patricia Latham, Autor Fecha de publicación: 2023 Artículo en la página: pp. 349-357 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Terapia de conducta cognitiva, Terapia de modalidad combinada, Motivación, Naltrexona, Antagonistas narcóticos, Índice de gravedad de la enfermedad Resumen: Although naltrexone has been shown to be effective in the treatment of alcohol dependence, less is known about its efficacy when combined with different behavioral therapies. Previous work has suggested that naltrexone works best when combined with weekly cognitive behavioral therapy (CBT). Link: ./index.php?lvl=notice_display&id=30901
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 349-357[artículo] Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence [texto impreso] / Raymond F. Anton, Autor ; Darlene H. Moak, Autor ; Patricia Latham, Autor . - 2023 . - pp. 349-357.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 349-357
Palabras clave: Alcoholismo, Terapia de conducta cognitiva, Terapia de modalidad combinada, Motivación, Naltrexona, Antagonistas narcóticos, Índice de gravedad de la enfermedad Resumen: Although naltrexone has been shown to be effective in the treatment of alcohol dependence, less is known about its efficacy when combined with different behavioral therapies. Previous work has suggested that naltrexone works best when combined with weekly cognitive behavioral therapy (CBT). Link: ./index.php?lvl=notice_display&id=30901
Título : Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Darlene H. Moak, Autor ; Patricia K. Latham, Autor Fecha de publicación: 2023 Artículo en la página: pp. 72-77 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Terapia de conducta cognitiva, Terapia de modalidad combinada, Naltrexona, Antagonistas narcóticos. Resumen: Naltrexone, an opiate antagonist medication, has been reported to be efficacious in the treatment of alcohol dependence when added to psychosocial treatments. Although the within-treatment efficacy of naltrexone has received primary attention, there has been little published on the outcome of individuals once the medication is discontinued. Link: ./index.php?lvl=notice_display&id=31140
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 72-77[artículo] Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism [texto impreso] / Raymond F. Anton, Autor ; Darlene H. Moak, Autor ; Patricia K. Latham, Autor . - 2023 . - pp. 72-77.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 72-77
Palabras clave: Alcoholismo, Terapia de conducta cognitiva, Terapia de modalidad combinada, Naltrexona, Antagonistas narcóticos. Resumen: Naltrexone, an opiate antagonist medication, has been reported to be efficacious in the treatment of alcohol dependence when added to psychosocial treatments. Although the within-treatment efficacy of naltrexone has received primary attention, there has been little published on the outcome of individuals once the medication is discontinued. Link: ./index.php?lvl=notice_display&id=31140
Título : A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Henry R. Kranzler, Autor ; Christopher Breder, Autor Fecha de publicación: 2023 Artículo en la página: pp. 5-12 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Antipsicóticos, Piperazinas, Quinolonas. Resumen: The purpose of this study was to compare the efficacy and safety of aripiprazole with placebo in the treatment of alcoholics. In this 12-week multicenter, double-blind study, 295 patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition alcohol dependence were randomized to treatment with aripiprazole (initiated at 2 mg/d, titrated to a maximum dose of 30mg/d at day 28) or placebo after screening, wherein patients maintained alcohol abstinence for 3 days or more. Link: ./index.php?lvl=notice_display&id=30866
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - pp. 5-12[artículo] A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence [texto impreso] / Raymond F. Anton, Autor ; Henry R. Kranzler, Autor ; Christopher Breder, Autor . - 2023 . - pp. 5-12.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - pp. 5-12
Palabras clave: Alcoholismo, Antipsicóticos, Piperazinas, Quinolonas. Resumen: The purpose of this study was to compare the efficacy and safety of aripiprazole with placebo in the treatment of alcoholics. In this 12-week multicenter, double-blind study, 295 patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition alcohol dependence were randomized to treatment with aripiprazole (initiated at 2 mg/d, titrated to a maximum dose of 30mg/d at day 28) or placebo after screening, wherein patients maintained alcohol abstinence for 3 days or more. Link: ./index.php?lvl=notice_display&id=30866
Permalink
